Researchers have identified a new signaling process involving G protein-coupled receptors (GPCRs), a cellular target already exploited by hundreds of diverse drugs. The discovery opens the possibility of new therapies, including for multiple forms of cancer.
from Top Health News -- ScienceDaily https://ift.tt/NMgp2uE
Post a Comment